[PMC free article: PMC6444791] [PubMed: 22166753] 63
R., Perlin, K., Potapenko, A., Savy, P., Sigh, S., Stecula, A., Thillaisundaram, A., Tong, C., Yakneen, S
Understanding these distinctions helps consumers evaluate options and have informed conversations with healthcare providers
Read the full FAQ here: #MunichReLifeNA #GLP1 #semagultide To view or add a comment, sign in When GLP-1 drugs like Ozempic and Wegovy moved from clinics to social media feeds, they became shorthand for weight loss sometimes framed as lifestyle choices rather than powerful, lifelong medications
Current research limitations include a small number of NAION cases among over 17,000 patients in the study, mainly white participants, and uncertainty regarding medication adherence